25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

0157 (Natural Beauty Bio-Technology Limited) Stock Analysis
Buy, Hold or Sell?

Let's analyze Natural Beauty Bio-Technology Limited together

I guess you are interested in Natural Beauty Bio-Technology Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Natural Beauty Bio-Technology Limited’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Natural Beauty Bio-Technology Limited’s Price Targets

I'm going to help you getting a better view of Natural Beauty Bio-Technology Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Natural Beauty Bio-Technology Limited

I send you an email if I find something interesting about Natural Beauty Bio-Technology Limited.

1. Quick Overview

1.1. Quick analysis of Natural Beauty Bio-Technology Limited (30 sec.)










1.2. What can you expect buying and holding a share of Natural Beauty Bio-Technology Limited? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
HK$0.22
Expected worth in 1 year
HK$-0.03
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
HK$-0.25
Return On Investment
-46.1%

For what price can you sell your share?

Current Price per Share
HK$0.55
Expected price per share
HK$0.51 - HK$0.61
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Natural Beauty Bio-Technology Limited (5 min.)




Live pricePrice per Share (EOD)
HK$0.55
Intrinsic Value Per Share
HK$-0.54 - HK$0.01
Total Value Per Share
HK$-0.32 - HK$0.23

2.2. Growth of Natural Beauty Bio-Technology Limited (5 min.)




Is Natural Beauty Bio-Technology Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$57.5m$73.8m-$16.3m-28.4%

How much money is Natural Beauty Bio-Technology Limited making?

Current yearPrevious yearGrowGrow %
Making money-$13.3m-$1.9m-$11.3m-85.4%
Net Profit Margin-29.3%-4.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Natural Beauty Bio-Technology Limited (5 min.)




2.4. Comparing to competitors in the Household & Personal Products industry (5 min.)




  Industry Rankings (Household & Personal Products)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Natural Beauty Bio-Technology Limited?

Welcome investor! Natural Beauty Bio-Technology Limited's management wants to use your money to grow the business. In return you get a share of Natural Beauty Bio-Technology Limited.

First you should know what it really means to hold a share of Natural Beauty Bio-Technology Limited. And how you can make/lose money.

Speculation

The Price per Share of Natural Beauty Bio-Technology Limited is HK$0.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Natural Beauty Bio-Technology Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Natural Beauty Bio-Technology Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.22. Based on the TTM, the Book Value Change Per Share is HK$-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Natural Beauty Bio-Technology Limited.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.01-1.2%-0.01-1.2%0.00-0.2%0.00-0.6%0.00-0.2%0.000.4%
Usd Book Value Change Per Share-0.01-1.5%-0.01-1.5%0.00-0.3%0.00-0.8%0.00-0.3%0.00-0.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.7%
Usd Total Gains Per Share-0.01-1.5%-0.01-1.5%0.00-0.3%0.00-0.8%0.00-0.2%0.000.3%
Usd Price Per Share0.06-0.06-0.06-0.06-0.07-0.09-
Price to Earnings Ratio-9.37--9.37--63.60--36.37-17.97-25.51-
Price-to-Total Gains Ratio-7.65--7.65--41.90--23.26--4.51--54.34-
Price to Book Ratio2.17-2.17-1.67-1.90-1.90-2.20-
Price-to-Total Gains Ratio-7.65--7.65--41.90--23.26--4.51--54.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.070675
Number of shares14149
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (14149 shares)-115.27-18.56
Gains per Year (14149 shares)-461.07-74.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-461-47113-87-84
20-922-93226-175-158
30-1383-139339-262-232
40-1844-185452-349-306
50-2305-231565-437-380
60-2766-277679-524-454
70-3228-323792-611-528
80-3689-3698105-699-602
90-4150-4159118-786-676
100-4611-4620131-873-750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%7.03.00.070.0%21.03.00.087.5%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%3.07.00.030.0%13.011.00.054.2%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%8.00.02.080.0%22.00.02.091.7%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%6.04.00.060.0%20.04.00.083.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Natural Beauty Bio-Technology Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.063-0.0630%-0.011-82%-0.035-45%-0.012-81%-0.016-74%
Book Value Per Share--0.2240.2240%0.287-22%0.270-17%0.289-23%0.302-26%
Current Ratio--1.5401.5400%1.211+27%1.402+10%1.610-4%2.506-39%
Debt To Asset Ratio--0.4210.4210%0.349+21%0.365+15%0.333+26%0.266+59%
Debt To Equity Ratio--0.7270.7270%0.536+36%0.581+25%0.508+43%0.379+92%
Dividend Per Share----0%-0%0.001-100%0.002-100%0.031-100%
Enterprise Value--762187952.020762187952.0200%819754447.360-7%855212303.993-11%964413006.076-21%1348551970.246-43%
Eps---0.052-0.0520%-0.008-85%-0.025-52%-0.011-80%0.017-412%
Ev To Ebitda Ratio---11.637-11.6370%35.778-133%29.771-139%26.207-144%21.020-155%
Ev To Sales Ratio--2.1552.1550%2.440-12%2.508-14%2.525-15%3.242-34%
Free Cash Flow Per Share---0.027-0.0270%-0.024-14%-0.023-16%-0.018-35%0.001-4637%
Free Cash Flow To Equity Per Share---0.020-0.0200%-0.002-88%-0.010-48%-0.006-71%-0.022+10%
Gross Profit Margin--2.6502.6500%10.153-74%6.124-57%-0.818+131%-1.339+151%
Intrinsic Value_10Y_max--0.010----------
Intrinsic Value_10Y_min---0.542----------
Intrinsic Value_1Y_max--0.001----------
Intrinsic Value_1Y_min---0.031----------
Intrinsic Value_3Y_max--0.002----------
Intrinsic Value_3Y_min---0.114----------
Intrinsic Value_5Y_max--0.004----------
Intrinsic Value_5Y_min---0.219----------
Market Cap1101154982.400+12%971018952.020971018952.0200%961008447.360+1%1011060970.660-4%1087140806.076-11%1332398170.246-27%
Net Profit Margin---0.293-0.2930%-0.045-85%-0.143-51%-0.067-77%0.063-565%
Operating Margin---0.275-0.2750%-0.011-96%-0.114-58%-0.046-83%0.095-391%
Operating Ratio--1.2751.2750%1.011+26%1.119+14%1.051+21%0.900+42%
Pb Ratio2.460+12%2.1692.1690%1.673+30%1.895+14%1.898+14%2.204-2%
Pe Ratio-10.627-13%-9.371-9.3710%-63.597+579%-36.368+288%17.973-152%25.506-137%
Price Per Share0.550+12%0.4850.4850%0.480+1%0.505-4%0.543-11%0.666-27%
Price To Free Cash Flow Ratio-20.037-13%-17.669-17.6690%-20.278+15%-22.850+29%27.523-164%11.239-257%
Price To Total Gains Ratio-8.675-13%-7.650-7.6500%-41.896+448%-23.256+204%-4.510-41%-54.339+610%
Quick Ratio--1.0061.0060%0.918+10%0.876+15%1.076-6%1.939-48%
Return On Assets---0.134-0.1340%-0.017-87%-0.062-54%-0.028-79%0.040-437%
Return On Equity---0.231-0.2310%-0.026-89%-0.103-56%-0.049-79%0.042-652%
Total Gains Per Share---0.063-0.0630%-0.011-82%-0.034-46%-0.010-84%0.014-542%
Usd Book Value--57515700.50057515700.5000%73826334.000-22%69371967.167-17%74240283.900-23%77696522.700-26%
Usd Book Value Change Per Share---0.008-0.0080%-0.001-82%-0.004-45%-0.002-81%-0.002-74%
Usd Book Value Per Share--0.0290.0290%0.037-22%0.035-17%0.037-23%0.039-26%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%0.004-100%
Usd Enterprise Value--97941151.83597941151.8350%105338446.486-7%109894781.063-11%123927071.281-21%173288928.177-43%
Usd Eps---0.007-0.0070%-0.001-85%-0.003-52%-0.001-80%0.002-412%
Usd Free Cash Flow---7061974.500-7061974.5000%-6089872.000-14%-5925220.667-16%-4560079.500-35%155639.200-4637%
Usd Free Cash Flow Per Share---0.004-0.0040%-0.003-14%-0.003-16%-0.002-35%0.000-4637%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%0.000-88%-0.001-48%-0.001-71%-0.003+10%
Usd Market Cap141498415.238+12%124775935.335124775935.3350%123489585.486+1%129921334.730-4%139697593.581-11%171213164.877-27%
Usd Price Per Share0.071+12%0.0620.0620%0.062+1%0.065-4%0.070-11%0.086-27%
Usd Profit---13314527.500-13314527.5000%-1941763.500-85%-6390647.667-52%-2728723.200-80%4274064.200-412%
Usd Revenue--45444153.50045444153.5000%43177927.500+5%43927553.667+3%49447545.300-8%52860839.400-14%
Usd Total Gains Per Share---0.008-0.0080%-0.001-82%-0.004-46%-0.001-84%0.002-542%
 EOD+5 -3MRQTTM+0 -0YOY+7 -313Y+5 -355Y+4 -3610Y+8 -32

3.3 Fundamental Score

Let's check the fundamental score of Natural Beauty Bio-Technology Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.627
Price to Book Ratio (EOD)Between0-12.460
Net Profit Margin (MRQ)Greater than0-0.293
Operating Margin (MRQ)Greater than0-0.275
Quick Ratio (MRQ)Greater than11.006
Current Ratio (MRQ)Greater than11.540
Debt to Asset Ratio (MRQ)Less than10.421
Debt to Equity Ratio (MRQ)Less than10.727
Return on Equity (MRQ)Greater than0.15-0.231
Return on Assets (MRQ)Greater than0.05-0.134
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Natural Beauty Bio-Technology Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.499
Ma 20Greater thanMa 500.555
Ma 50Greater thanMa 1000.551
Ma 100Greater thanMa 2000.529
OpenGreater thanClose0.550
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Natural Beauty Bio-Technology Limited

Natural Beauty Bio-Technology Limited, an investment holding company, provides skin care products and services in Mainland China, Taiwan, and internationally. It manufactures and sells skin care, beauty, aroma-therapeutic, and make-up products, as well as health supplements under the Natural Beauty brand. The company also offers skin treatments, beauty services, medical cosmetology services, and skin care consulting and beauty training services, as well as beauty apparatus. In addition, its spas provide hydrotherapy, facial treatment, body care, and skin care analysis services. Further, the company engages in the wholesale of skin care and beauty products. Natural Beauty Bio-Technology Limited was founded in 1976 and is based in Causeway Bay, Hong Kong.

Fundamental data was last updated by Penke on 2025-09-11 03:02:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Natural Beauty Bio-Technology Limited earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Natural Beauty Bio-Technology Limited to theΒ Household & Personal Products industry mean.
  • A Net Profit Margin of -29.3%Β means thatΒ $-0.29 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Natural Beauty Bio-Technology Limited:

  • The MRQ is -29.3%. The company is making a huge loss. -2
  • The TTM is -29.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-29.3%TTM-29.3%0.0%
TTM-29.3%YOY-4.5%-24.8%
TTM-29.3%5Y-6.7%-22.5%
5Y-6.7%10Y6.3%-13.0%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.3%4.6%-33.9%
TTM-29.3%3.7%-33.0%
YOY-4.5%5.5%-10.0%
3Y-14.3%4.1%-18.4%
5Y-6.7%4.5%-11.2%
10Y6.3%5.7%+0.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Natural Beauty Bio-Technology Limited is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Natural Beauty Bio-Technology Limited to theΒ Household & Personal Products industry mean.
  • -13.4% Return on Assets means thatΒ Natural Beauty Bio-Technology Limited generatedΒ $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Natural Beauty Bio-Technology Limited:

  • The MRQ is -13.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.4%TTM-13.4%0.0%
TTM-13.4%YOY-1.7%-11.7%
TTM-13.4%5Y-2.8%-10.6%
5Y-2.8%10Y4.0%-6.8%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.4%1.6%-15.0%
TTM-13.4%1.4%-14.8%
YOY-1.7%1.9%-3.6%
3Y-6.2%1.4%-7.6%
5Y-2.8%1.3%-4.1%
10Y4.0%1.6%+2.4%
4.3.1.3. Return on Equity

Shows how efficient Natural Beauty Bio-Technology Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Natural Beauty Bio-Technology Limited to theΒ Household & Personal Products industry mean.
  • -23.1% Return on Equity means Natural Beauty Bio-Technology Limited generated $-0.23Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Natural Beauty Bio-Technology Limited:

  • The MRQ is -23.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -23.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23.1%TTM-23.1%0.0%
TTM-23.1%YOY-2.6%-20.5%
TTM-23.1%5Y-4.9%-18.3%
5Y-4.9%10Y4.2%-9.0%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.1%3.3%-26.4%
TTM-23.1%2.7%-25.8%
YOY-2.6%3.4%-6.0%
3Y-10.3%2.5%-12.8%
5Y-4.9%2.6%-7.5%
10Y4.2%3.3%+0.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Natural Beauty Bio-Technology Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Natural Beauty Bio-Technology Limited is operatingΒ .

  • Measures how much profit Natural Beauty Bio-Technology Limited makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Natural Beauty Bio-Technology Limited to theΒ Household & Personal Products industry mean.
  • An Operating Margin of -27.5%Β means the company generated $-0.27 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Natural Beauty Bio-Technology Limited:

  • The MRQ is -27.5%. The company is operating very inefficient. -2
  • The TTM is -27.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-27.5%TTM-27.5%0.0%
TTM-27.5%YOY-1.1%-26.4%
TTM-27.5%5Y-4.6%-22.9%
5Y-4.6%10Y9.5%-14.0%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.5%9.5%-37.0%
TTM-27.5%7.1%-34.6%
YOY-1.1%8.6%-9.7%
3Y-11.4%4.1%-15.5%
5Y-4.6%5.9%-10.5%
10Y9.5%7.6%+1.9%
4.3.2.2. Operating Ratio

Measures how efficient Natural Beauty Bio-Technology Limited is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Household & Personal Products industry mean).
  • An Operation Ratio of 1.27 means that the operating costs are $1.27 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Natural Beauty Bio-Technology Limited:

  • The MRQ is 1.275. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.275. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.275TTM1.2750.000
TTM1.275YOY1.011+0.264
TTM1.2755Y1.051+0.224
5Y1.05110Y0.900+0.151
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2751.090+0.185
TTM1.2751.091+0.184
YOY1.0110.976+0.035
3Y1.1191.037+0.082
5Y1.0511.016+0.035
10Y0.9000.974-0.074
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Natural Beauty Bio-Technology Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Natural Beauty Bio-Technology Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Household & Personal Products industry mean).
  • A Current Ratio of 1.54Β means the company has $1.54 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Natural Beauty Bio-Technology Limited:

  • The MRQ is 1.540. The company is able to pay all its short-term debts. +1
  • The TTM is 1.540. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.540TTM1.5400.000
TTM1.540YOY1.211+0.329
TTM1.5405Y1.610-0.070
5Y1.61010Y2.506-0.896
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5401.739-0.199
TTM1.5401.743-0.203
YOY1.2111.814-0.603
3Y1.4021.831-0.429
5Y1.6101.869-0.259
10Y2.5061.757+0.749
4.4.3.2. Quick Ratio

Measures if Natural Beauty Bio-Technology Limited is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Natural Beauty Bio-Technology Limited to theΒ Household & Personal Products industry mean.
  • A Quick Ratio of 1.01Β means the company can pay off $1.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Natural Beauty Bio-Technology Limited:

  • The MRQ is 1.006. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.006. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.006TTM1.0060.000
TTM1.006YOY0.918+0.088
TTM1.0065Y1.076-0.069
5Y1.07610Y1.939-0.863
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0060.810+0.196
TTM1.0060.876+0.130
YOY0.9180.939-0.021
3Y0.8760.951-0.075
5Y1.0761.035+0.041
10Y1.9391.035+0.904
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Natural Beauty Bio-Technology Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Natural Beauty Bio-Technology LimitedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Natural Beauty Bio-Technology Limited to Household & Personal Products industry mean.
  • A Debt to Asset Ratio of 0.42Β means that Natural Beauty Bio-Technology Limited assets areΒ financed with 42.1% credit (debt) and the remaining percentage (100% - 42.1%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Natural Beauty Bio-Technology Limited:

  • The MRQ is 0.421. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.421. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.421TTM0.4210.000
TTM0.421YOY0.349+0.072
TTM0.4215Y0.333+0.088
5Y0.33310Y0.266+0.067
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4210.417+0.004
TTM0.4210.419+0.002
YOY0.3490.439-0.090
3Y0.3650.433-0.068
5Y0.3330.436-0.103
10Y0.2660.440-0.174
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Natural Beauty Bio-Technology Limited is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Natural Beauty Bio-Technology Limited to theΒ Household & Personal Products industry mean.
  • A Debt to Equity ratio of 72.7% means that company has $0.73 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Natural Beauty Bio-Technology Limited:

  • The MRQ is 0.727. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.727. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.727TTM0.7270.000
TTM0.727YOY0.536+0.191
TTM0.7275Y0.508+0.218
5Y0.50810Y0.379+0.129
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7270.707+0.020
TTM0.7270.706+0.021
YOY0.5360.773-0.237
3Y0.5810.736-0.155
5Y0.5080.758-0.250
10Y0.3790.790-0.411
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Natural Beauty Bio-Technology Limited generates.

  • Above 15 is considered overpriced butΒ always compareΒ Natural Beauty Bio-Technology Limited to theΒ Household & Personal Products industry mean.
  • A PE ratio of -9.37 means the investor is paying $-9.37Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Natural Beauty Bio-Technology Limited:

  • The EOD is -10.627. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.371. Based on the earnings, the company is expensive. -2
  • The TTM is -9.371. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.627MRQ-9.371-1.256
MRQ-9.371TTM-9.3710.000
TTM-9.371YOY-63.597+54.225
TTM-9.3715Y17.973-27.345
5Y17.97310Y25.506-7.533
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-10.62712.485-23.112
MRQ-9.37112.438-21.809
TTM-9.37112.603-21.974
YOY-63.59715.933-79.530
3Y-36.36815.716-52.084
5Y17.97315.638+2.335
10Y25.50619.114+6.392
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Natural Beauty Bio-Technology Limited:

  • The EOD is -20.037. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -17.669. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.669. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.037MRQ-17.669-2.368
MRQ-17.669TTM-17.6690.000
TTM-17.669YOY-20.278+2.609
TTM-17.6695Y27.523-45.192
5Y27.52310Y11.239+16.284
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-20.0376.512-26.549
MRQ-17.6696.208-23.877
TTM-17.6695.539-23.208
YOY-20.2786.298-26.576
3Y-22.8505.906-28.756
5Y27.5235.023+22.500
10Y11.2395.308+5.931
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Natural Beauty Bio-Technology Limited is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Household & Personal Products industry mean).
  • A PB ratio of 2.17 means the investor is paying $2.17Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Natural Beauty Bio-Technology Limited:

  • The EOD is 2.460. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.169. Based on the equity, the company is underpriced. +1
  • The TTM is 2.169. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.460MRQ2.169+0.291
MRQ2.169TTM2.1690.000
TTM2.169YOY1.673+0.497
TTM2.1695Y1.898+0.272
5Y1.89810Y2.204-0.307
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD2.4601.452+1.008
MRQ2.1691.555+0.614
TTM2.1691.549+0.620
YOY1.6731.713-0.040
3Y1.8951.860+0.035
5Y1.8982.012-0.114
10Y2.2042.728-0.524
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Retained Earnings  50,31035,12285,432-30,87054,562-15,44139,121-103,615-64,494
EBITDA  41,57243,66085,232-70,13815,0947,81822,912-88,407-65,495
Tax Provision  1,22511,97013,195-6,2716,924-3,6823,242-4,834-1,592
Income Tax Expense  1,22511,97013,195-6,2716,924-3,6823,242-4,834-1,592



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets772,931
Total Liabilities325,338
Total Stockholder Equity447,593
 As reported
Total Liabilities 325,338
Total Stockholder Equity+ 447,593
Total Assets = 772,931

Assets

Total Assets772,931
Total Current Assets288,759
Long-term Assets484,172
Total Current Assets
Cash And Cash Equivalents 116,507
Net Receivables 72,198
Inventory 81,204
Other Current Assets 18,850
Total Current Assets  (as reported)288,759
Total Current Assets  (calculated)288,759
+/-0
Long-term Assets
Property Plant Equipment 274,485
Long-term Assets Other 191,564
Long-term Assets  (as reported)484,172
Long-term Assets  (calculated)466,049
+/- 18,123

Liabilities & Shareholders' Equity

Total Current Liabilities187,508
Long-term Liabilities137,830
Total Stockholder Equity447,593
Total Current Liabilities
Short-term Debt 74,299
Short Long Term Debt 68,209
Accounts payable 25,604
Other Current Liabilities 83,680
Total Current Liabilities  (as reported)187,508
Total Current Liabilities  (calculated)251,792
+/- 64,284
Long-term Liabilities
Long term Debt Total 137,830
Long-term Liabilities  (as reported)137,830
Long-term Liabilities  (calculated)137,830
+/-0
Total Stockholder Equity
Common Stock200,210
Retained Earnings -64,494
Capital Surplus 29,004
Other Stockholders Equity 311,877
Total Stockholder Equity (as reported)447,593
Total Stockholder Equity (calculated)476,597
+/- 29,004
Other
Capital Stock200,210
Cash and Short Term Investments 116,507
Common Stock Shares Outstanding 2,002,101
Liabilities and Stockholders Equity 772,931
Net Debt 95,622
Net Invested Capital 639,845
Net Working Capital 101,251
Property Plant and Equipment Gross 539,388
Short Long Term Debt Total 212,129



6.3. Balance Sheets Structured

Currency in HKD. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
> Total Assets 
647,489
861,486
841,415
900,231
937,470
997,660
1,032,314
1,026,226
999,319
940,931
958,626
884,060
982,067
977,730
888,597
822,186
777,885
678,966
768,133
840,768
937,161
883,532
882,583
772,931
772,931882,583883,532937,161840,768768,133678,966777,885822,186888,597977,730982,067884,060958,626940,931999,3191,026,2261,032,314997,660937,470900,231841,415861,486647,489
   > Total Current Assets 
258,902
458,761
431,272
510,600
563,181
612,678
758,991
740,514
734,512
667,326
655,186
555,241
667,392
696,087
609,610
565,936
491,856
347,785
359,499
399,782
450,012
364,619
343,285
288,759
288,759343,285364,619450,012399,782359,499347,785491,856565,936609,610696,087667,392555,241655,186667,326734,512740,514758,991612,678563,181510,600431,272458,761258,902
       Cash And Cash Equivalents 
76,110
216,778
170,265
235,920
338,748
356,243
588,741
546,205
559,346
575,488
558,735
432,441
507,409
583,283
502,721
428,633
288,903
181,024
138,971
158,150
188,211
160,592
158,743
116,507
116,507158,743160,592188,211158,150138,971181,024288,903428,633502,721583,283507,409432,441558,735575,488559,346546,205588,741356,243338,748235,920170,265216,77876,110
       Short-term Investments 
65,750
88,133
67,642
94,378
26,491
27,713
0
428
430
432
443
0
0
0
5,491
1,706
7,338
2,857
10,140
7,456
8,871
8,017
8,062
0
08,0628,0178,8717,45610,1402,8577,3381,7065,491000443432430428027,71326,49194,37867,64288,13365,750
       Net Receivables 
0
101,132
130,659
123,553
141,229
164,905
-9,381
-3,582
74,119
44,681
46,053
55,071
83,680
50,802
41,210
72,972
98,151
71,350
98,950
113,712
115,157
-281
85,359
72,198
72,19885,359-281115,157113,71298,95071,35098,15172,97241,21050,80283,68055,07146,05344,68174,119-3,582-9,381164,905141,229123,553130,659101,1320
       Inventory 
52,674
52,718
62,706
55,726
56,477
63,573
71,017
100,859
89,076
46,725
40,260
67,427
47,047
45,036
46,905
49,842
85,077
74,313
85,492
103,280
120,961
98,831
77,614
81,204
81,20477,61498,831120,961103,28085,49274,31385,07749,84246,90545,03647,04767,42740,26046,72589,076100,85971,01763,57356,47755,72662,70652,71852,674
       Other Current Assets 
64,368
101,132
198,301
1,023
167,956
192,862
99,233
93,450
86,090
44,681
10,138
12,437
29,568
17,276
18,774
14,489
19,725
21,098
27,020
17,909
17,219
97,460
13,507
18,850
18,85013,50797,46017,21917,90927,02021,09819,72514,48918,77417,27629,56812,43710,13844,68186,09093,45099,233192,862167,9561,023198,301101,13264,368
   > Long-term Assets 
388,587
402,725
410,143
389,631
374,289
384,982
273,323
285,712
264,807
273,605
303,440
328,819
285,593
251,980
214,397
199,052
225,705
245,736
408,634
440,986
487,149
518,913
539,536
484,172
484,172539,536518,913487,149440,986408,634245,736225,705199,052214,397251,980285,593328,819303,440273,605264,807285,712273,323384,982374,289389,631410,143402,725388,587
       Property Plant Equipment 
377,660
362,186
352,527
353,415
338,378
335,707
218,025
230,569
217,760
232,078
261,106
285,065
257,218
223,708
187,351
173,542
198,610
197,207
344,963
369,559
417,055
238,368
270,650
274,485
274,485270,650238,368417,055369,559344,963197,207198,610173,542187,351223,708257,218285,065261,106232,078217,760230,569218,025335,707338,378353,415352,527362,186377,660
       Goodwill 
0
11,200
23,625
16,801
13,898
23,207
24,562
25,766
25,833
26,640
27,507
27,643
28,375
28,272
27,046
25,510
27,095
31,407
27,383
28,818
29,613
25,678
25,158
0
025,15825,67829,61328,81827,38331,40727,09525,51027,04628,27228,37527,64327,50726,64025,83325,76624,56223,20713,89816,80123,62511,2000
       Intangible Assets 
5,461
16,466
3,203
2,137
927
32,326
34,078
35,575
35,395
36,276
37,217
9,465
9,453
9,102
27,046
25,510
27,095
17,122
42,400
42,872
35,264
25,678
0
0
0025,67835,26442,87242,40017,12227,09525,51027,0469,1029,4539,46537,21736,27635,39535,57534,07832,3269272,1373,20316,4665,461
       Other Assets 
0
16,031
18,564
12,024
164,369
171,665
12,094
13,642
7,726
5,251
5,117
28,414
29,082
29,663
64,590
57,198
60,324
85,445
10,109
22,042
0
243,599
-238
19,666
19,666-238243,599022,04210,10985,44560,32457,19864,59029,66329,08228,4145,1175,2517,72613,64212,094171,665164,36912,02418,56416,0310
> Total Liabilities 
164,877
107,034
80,827
95,600
117,173
118,489
116,663
169,819
130,491
158,297
170,441
136,064
193,809
203,824
155,969
167,513
127,139
127,111
200,340
229,538
279,243
286,070
308,059
325,338
325,338308,059286,070279,243229,538200,340127,111127,139167,513155,969203,824193,809136,064170,441158,297130,491169,819116,663118,489117,17395,60080,827107,034164,877
   > Total Current Liabilities 
158,101
99,436
72,451
85,435
106,283
107,172
104,764
157,560
118,616
145,702
155,110
125,958
180,833
191,202
143,637
162,726
115,652
125,812
158,216
204,665
237,966
250,777
283,360
187,508
187,508283,360250,777237,966204,665158,216125,812115,652162,726143,637191,202180,833125,958155,110145,702118,616157,560104,764107,172106,28385,43572,45199,436158,101
       Short-term Debt 
2,112
0
0
0
0
0
0
0
0
0
0
0
0
0
-6,593
-6,223
-5,981
-22,616
22,122
59,486
94,816
119,408
171,737
74,299
74,299171,737119,40894,81659,48622,122-22,616-5,981-6,223-6,59300000000000002,112
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,556
54,273
87,801
113,842
168,309
68,209
68,209168,309113,84287,80154,27314,556000000000000000000
       Accounts payable 
135,211
69,487
53,675
60,160
82,041
70,198
90,308
105,979
12,079
13,032
22,349
18,005
21,266
18,577
14,942
20,880
21,521
20,537
26,242
26,147
15,151
9,764
20,741
25,604
25,60420,7419,76415,15126,14726,24220,53721,52120,88014,94218,57721,26618,00522,34913,03212,079105,97990,30870,19882,04160,16053,67569,487135,211
       Other Current Liabilities 
20,778
18,646
5,244
4,526
8,345
8,092
9,745
10,374
92,047
123,625
113,483
89,313
132,907
128,872
94,066
111,318
69,761
72,964
77,816
97,520
95,170
97,260
87,854
83,680
83,68087,85497,26095,17097,52077,81672,96469,761111,31894,066128,872132,90789,313113,483123,62592,04710,3749,7458,0928,3454,5265,24418,64620,778
   > Long-term Liabilities 
6,776
7,598
8,376
10,165
10,890
11,317
11,899
12,259
11,875
12,595
15,331
10,106
12,976
12,622
12,332
4,787
11,487
1,299
42,124
24,873
41,277
35,293
24,699
137,830
137,83024,69935,29341,27724,87342,1241,29911,4874,78712,33212,62212,97610,10615,33112,59511,87512,25911,89911,31710,89010,1658,3767,5986,776
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,371
15,535
34,258
24,070
14,550
137,830
137,83014,55024,07034,25815,53548,371000000000000000000
       Other Liabilities 
0
7,598
8,376
10,165
10,890
11,317
11,899
12,259
11,875
10,493
10,009
10,106
12,976
12,622
12,332
4,787
11,487
1,299
652
542
302
0
0
0
0003025426521,29911,4874,78712,33212,62212,97610,10610,00910,49311,87512,25911,89911,31710,89010,1658,3767,5980
> Total Stockholder Equity
454,343
734,130
750,389
794,969
813,511
878,739
909,626
849,960
868,082
782,487
788,004
748,183
788,258
773,906
732,628
654,673
650,746
551,855
567,793
611,230
657,918
597,462
574,524
447,593
447,593574,524597,462657,918611,230567,793551,855650,746654,673732,628773,906788,258748,183788,004782,487868,082849,960909,626878,739813,511794,969750,389734,130454,343
   Common Stock
0
200,000
200,000
200,000
200,000
200,000
200,000
200,064
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210
200,210200,210200,210200,210200,210200,210200,210200,210200,210200,210200,210200,210200,210200,210200,210200,210200,064200,000200,000200,000200,000200,000200,0000
   Retained Earnings 
105,612
118,192
108,308
114,512
230,105
273,303
267,010
505,487
518,047
399,192
354,147
169,778
365,009
361,323
355,497
314,015
258,955
189,113
42,755
50,310
85,432
54,562
39,121
-64,494
-64,49439,12154,56285,43250,31042,755189,113258,955314,015355,497361,323365,009169,778354,147399,192518,047505,487267,010273,303230,105114,512108,308118,192105,612
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,016
41,016
41,016
41,016
41,016
41,016
35,010
29,004
29,004
29,004
29,00429,00429,00435,01041,01641,01641,01641,01641,01641,01600000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
348,731
615,938
750,389
794,969
336,758
536,758
336,758
38,024
41,016
41,016
83,570
83,570
83,570
-79,920
83,570
-79,920
83,570
83,570
83,570
83,570
-102,156
71,558
71,558
311,877
311,87771,55871,558-102,15683,57083,57083,57083,570-79,92083,570-79,92083,57083,57083,57041,01641,01638,024336,758536,758336,758794,969750,389615,938348,731



6.4. Balance Sheets

Currency in HKD. All numbers in thousands.




6.5. Cash Flows

Currency in HKD. All numbers in thousands.




6.6. Income Statements

Currency in HKD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in HKD. All numbers in thousands.

Gross Profit (+$)
totalRevenue353,651
Cost of Revenue-151,321
Gross Profit202,330202,330
 
Operating Income (+$)
Gross Profit202,330
Operating Expense-299,492
Operating Income-97,162-97,162
 
Operating Expense (+$)
Research Development0
Selling General Administrative80,372
Selling And Marketing Expenses171,014
Operating Expense299,492251,386
 
Net Interest Income (+$)
Interest Income8,045
Interest Expense-8,045
Other Finance Cost-7,198
Net Interest Income-7,198
 
Pretax Income (+$)
Operating Income-97,162
Net Interest Income-7,198
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-105,207-89,117
EBIT - interestExpense = -105,207
-105,207
-95,570
Interest Expense8,045
Earnings Before Interest and Taxes (EBIT)-97,162-97,162
Earnings Before Interest and Taxes (EBITDA)-65,495
 
After tax Income (+$)
Income Before Tax-105,207
Tax Provision--1,592
Net Income From Continuing Ops-103,615-103,615
Net Income-103,615
Net Income Applicable To Common Shares-103,615
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses450,813
Total Other Income/Expenses Net-8,0457,198
 

Technical Analysis of Natural Beauty Bio-Technology Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Natural Beauty Bio-Technology Limited. The general trend of Natural Beauty Bio-Technology Limited is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Natural Beauty Bio-Technology Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Natural Beauty Bio-Technology Limited Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Natural Beauty Bio-Technology Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.56 < 0.56 < 0.61.

The bearish price targets are: 0.54 > 0.51 > 0.51.

Know someone who trades $0157? Share this with them.πŸ‘‡

Natural Beauty Bio-Technology Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Natural Beauty Bio-Technology Limited. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Natural Beauty Bio-Technology Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Natural Beauty Bio-Technology Limited. The current macd is 0.00031002.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Natural Beauty Bio-Technology Limited price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Natural Beauty Bio-Technology Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Natural Beauty Bio-Technology Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Natural Beauty Bio-Technology Limited Daily Moving Average Convergence/Divergence (MACD) ChartNatural Beauty Bio-Technology Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Natural Beauty Bio-Technology Limited. The current adx is 40.14.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Natural Beauty Bio-Technology Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Natural Beauty Bio-Technology Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Natural Beauty Bio-Technology Limited. The current sar is 0.62146944.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Natural Beauty Bio-Technology Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Natural Beauty Bio-Technology Limited. The current rsi is 48.50. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Natural Beauty Bio-Technology Limited Daily Relative Strength Index (RSI) ChartNatural Beauty Bio-Technology Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Natural Beauty Bio-Technology Limited. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Natural Beauty Bio-Technology Limited price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Natural Beauty Bio-Technology Limited Daily Stochastic Oscillator ChartNatural Beauty Bio-Technology Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Natural Beauty Bio-Technology Limited. The current cci is -73.41269841.

Natural Beauty Bio-Technology Limited Daily Commodity Channel Index (CCI) ChartNatural Beauty Bio-Technology Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Natural Beauty Bio-Technology Limited. The current cmo is -7.74657705.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Natural Beauty Bio-Technology Limited Daily Chande Momentum Oscillator (CMO) ChartNatural Beauty Bio-Technology Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Natural Beauty Bio-Technology Limited. The current willr is -88.88888889.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Natural Beauty Bio-Technology Limited Daily Williams %R ChartNatural Beauty Bio-Technology Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Natural Beauty Bio-Technology Limited.

Natural Beauty Bio-Technology Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Natural Beauty Bio-Technology Limited. The current atr is 0.01056226.

Natural Beauty Bio-Technology Limited Daily Average True Range (ATR) ChartNatural Beauty Bio-Technology Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Natural Beauty Bio-Technology Limited. The current obv is 6,715,000.

Natural Beauty Bio-Technology Limited Daily On-Balance Volume (OBV) ChartNatural Beauty Bio-Technology Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Natural Beauty Bio-Technology Limited. The current mfi is 49.81.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Natural Beauty Bio-Technology Limited Daily Money Flow Index (MFI) ChartNatural Beauty Bio-Technology Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Natural Beauty Bio-Technology Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-20ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-28BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-11STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Natural Beauty Bio-Technology Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Natural Beauty Bio-Technology Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.499
Ma 20Greater thanMa 500.555
Ma 50Greater thanMa 1000.551
Ma 100Greater thanMa 2000.529
OpenGreater thanClose0.550
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Natural Beauty Bio-Technology Limited with someone you think should read this too:
  • Are you bullish or bearish on Natural Beauty Bio-Technology Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Natural Beauty Bio-Technology Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Natural Beauty Bio-Technology Limited

I send you an email if I find something interesting about Natural Beauty Bio-Technology Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Natural Beauty Bio-Technology Limited.

Receive notifications about Natural Beauty Bio-Technology Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.